新型手术前碳水化合物饮料与商业糖饮料对胃空气,血糖反应和禁食不适:试点随机交叉试验
Chaitong Churuangsuk1, Khanin Khanungwanitkul2, Anukoon Kaewborisutsakul3
1Clinical Nutrition and Obesity Medicine Unit, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
Nutrients
|July 12, 2025
概括
一种新的碳水化合物饮料显示出安全的胃排空,类似于甜饮,但在试点研究中提供了更持续的血糖反应. 这为手术前的碳水化合物负载提供了潜在的改进选择.
科学领域:
- 麻醉学 麻醉学
- 胃肠病学 胃肠病学
- 营养科学 营养科学
背景情况:
- 手术后增强恢复 (ERAS) 准则提倡进行手术前碳水化合物加重.
- 目前的医院实践往往使用糖缩糖饮料,而不是专用配方.
- 这项研究研究了一种新的碳水化合物饮料,与传统的选择对比.
研究的目的:
- 为了比较新的碳水化合物饮料与糖缩糖的胃空化,血糖反应和禁食不适,糖缩糖饮料.
- 评估不同手术前碳水化合物加载策略的安全性和有效性.
主要方法:
- 一项试点随机交叉试验,涉及16名健康志愿者.
- 进行了三种干预措施:新型碳水化合物饮料400毫升 (C400),新型碳水化合物饮料250毫升 (C250) 和糖甜饮料250毫升 (SYR),一周的洗期.
- 通过超声波 (胃腹部横截面区域) 评估胃空气,以及血糖反应和对口渴和饥饿的视觉模拟尺度.
主要成果:
- 所有测试的饮料都表现出相似的胃空化概况,在摄入后120分钟后恢复到基线.
- 新型碳水化合物饮料 (C400和C250) 与糖甜饮料 (SYR) 相比,在60分钟和120分钟内诱导更高和更持续的葡萄糖峰值.
- 所有饮料都同样减少了口渴和口腔干燥,而饥饿感在120分钟后逐渐增加.
结论:
- 新型碳水化合物饮料,无论是400毫升和250毫升的体积,都显示出安全的胃排空特性.
- 这些新的饮料提供了与糖缩糖饮料相比较的胃空气.
- 新型配方提供了更持久的血糖反应,可能会增强手术前碳水化合物加载协议.
相关概念视频
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
267
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
267
Hypoglycemia and Glucagon
342
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
342
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
178
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
178
Gastric Emptying
1.5K
Gastric emptying occurs when the stomach gradually releases chyme into the duodenum. When the stomach is distended, it triggers the release of gastrin, a hormone that promotes gastric acid secretion to aid in digestion. Additionally, stomach distension contributes to peristaltic waves that propel gastric contents toward the pyloric region. The gastroenteric reflex, on the other hand, primarily stimulates peristalsis in the intestines, facilitating the movement of contents further along the...
1.5K
SBAR II: Application of SBAR
4.8K
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.8K
Endoscopic Procedures I: Esophagogastroduodenoscopy
356
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
During an EGD, the endoscope can be used to:
356

![Assessment of Gastric Emptying in Non-obese Diabetic Mice Using a [13C]-octanoic Acid Breath Test](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F50301.jpg&w=3840&q=50)
